Skip to main content

New collection: Advances in CAR-T immunotherapy

Chimeric antigen receptor (CAR) T cells therapies, as a novel modality in cancer immunotherapy, provide a quantum leap in the treatment of cancer.  BMC Cancer and BMC Biotechnology together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click on highlight to read the the full collection of articles. 

Collection: Hepatitis C

The 2020 Nobel Prize for Physiology or Medicine was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.

Focus Issue Health Disparities

New Content Item


With World Humanitarian Day falling on 19th August, the BMC Series decided to focus on health disparities in August’s focus issue. Browse our biology, chemistry and medical titles for insight into health disparities, including racial health disparities, socioeconomic health disparities and regional disparities

Articles

Featured review: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico

Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently presenting at an advanced stage. While rare in the United States overall, gallbladder cancer has an elevated incidence in geographically distinct locations of the globe including Chile, North India, Korea, Japan and the state of New Mexico in the United States. Rama R. Gullapalli, Associate Editor for BMC Cancer provides this review.

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article

Featured review: A stepwise approach to constructing systematic reviews

New Content ItemSystematic reviews, with or without meta-analysis, play an important role today in synthesizing cancer research and are frequently used to guide decision-making. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results. 

Read More

Featured article: Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.

Aims and scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Journal Sections


BMC Series Focus Issue

October: Animal Models

With World Animal Day falling on October 4th, the BMC series has decided to dedicate this month’s focus issue to animal models. Browse our titles for insight into recent research in the field, including growth regulation, lifespan variation,  nephrotoxicity,   cancer, lipid metabolism, autism, temperature-dependent development,  drug resistance, inflammatory responses,  disease resistance, sperm dynamics and antimicrobial residues in fish.

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last 6 months!

Read our highly accessed articles

New Content ItemEGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

New Content ItemEstimation of immune cell content in tumor using single-cell RNA-seq reference data

New Content ItemDynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study​​​​​​​

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

2019 Journal Metrics

  • Citation Impact
    3.15 -   2-year Impact Factor
    3.432 - 5-year Impact Factor
    1.021 - Source Normalized Impact per Paper (SNIP)
    1.186 - SCImago Journal Rank (SJR)

    Usage 

    4,151,734 downloads

    Social Media Impact 

    3364 mentions